Key statistics
On Monday, Actinogen Medical Ltd (ATGGF:PKC) closed at 0.015, 0.00% below its 52-week high of 0.015, set on Sep 09, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.015 |
---|---|
High | 0.015 |
Low | 0.015 |
Bid | -- |
Offer | -- |
Previous close | 0.015 |
Average volume | -- |
---|---|
Shares outstanding | 2.71bn |
Free float | 2.28bn |
P/E (TTM) | -- |
Market cap | 73.24m AUD |
EPS (TTM) | -0.0061 AUD |
Data delayed at least 15 minutes, as of Sep 09 2024 17:09 BST.
More ▼
Press releases
- Actinogen announces further positive results on depression in the XanCIDD phase 2a trial
- Actinogen announces achievement of clinically and statistically significant superiority of Xanamem® over placebo on depression in XanaCIDD phase 2a trial
- Positive Xanamem® biomarker trial published in the Journal of Alzheimer's Disease demonstrating potential Xanamem efficacy in patients with elevated blood pTau